Summarize with ChatGPT
Extracorporeal Magnetotransduction Therapy (EMTT) and extracorporeal shockwave therapy (ESWT) are both non-invasive, regenerative modalities for musculoskeletal conditions — but they rely on fundamentally different physics and suit different practices. EMTT delivers high-intensity pulsed electromagnetic fields; shockwave systems like SoftWave deliver broad-focused acoustic waves. This guide compares EMTT vs. shockwave therapy across mechanism, clinical evidence, FDA clearances, patient comfort, treatment time, and cost — so you can decide which technology to add to your practice.
- What Is Extracorporeal Magnetotransduction Therapy (EMTT)?
- How Does Extracorporeal Magnetotransduction Therapy Work?
- Clinical Indications for Extracorporeal Magnetotransduction Therapy
- Comparing EMTT to ESWT (SoftWave)
What Is EMTT (Extracorporeal Magnetotransduction Therapy)?
Extracorporeal Magnetotransduction Therapy (EMTT) is a novel, non-invasive therapeutic approach that utilizes high-intensity electromagnetic fields to stimulate biological processes in musculoskeletal tissues. Operating at oscillation frequencies ranging from 100 to 300 kHz and magnetic field strengths up to 80 mT, EMTT is distinct from traditional electromagnetic therapies like Pulsed Electromagnetic Field (PEMF) therapy, which employs lower frequencies and field strengths. These enhanced physical parameters allow EMTT to achieve deeper tissue penetration and more pronounced biological effects.
How EMTT Differs From Earlier Electromagnetic Therapies
EMTT represents an evolution of Electromagnetic Transduction Therapy, building on the foundational principles of electromagnetic stimulation but advancing its therapeutic capabilities through higher-frequency waves and increased magnetic field strength. Unlike earlier methods, EMTT targets deeper tissue structures with greater precision, offering potential benefits for complex musculoskeletal conditions.
How Does Extracorporeal Magnetotransduction Therapy Work?
At the cellular level, EMTT enhances osteoblastogenesis by upregulating critical bone-related genes such as RUNX2, SP7, COL1A1, and ALPL, which are integral to bone formation and extracellular matrix mineralization. Gerdesmeyer et al. (2024) ddemonstrated that EMTT significantly increases calcium influx in osteoblasts, a key driver of differentiation and mineralization. By promoting calcium signaling, EMTT accelerates hydroxyapatite deposition, strengthening the bone matrix. EMTT also stimulates collagen synthesis — essential to bone tissue integrity — as evidenced by increased Sirius Red staining and collagen type I production in stimulated cells.
EMTT and Soft Tissue Repair: What the Evidence Shows
The therapy’s non-invasive mechanism relies on electroporation and piezoelectric effects that facilitate cellular communication and tissue regeneration, further supported by Knobloch (2022), which highlights EMTT’s ability to reduce inflammation and enhance tissue repair in soft tissue injuries. For a purchasing provider, the takeaway is that EMTT’s evidence is concentrated in bone and regeneration — a narrower lane than a broad-focused shockwave system covers.
What Is Shockwave Therapy? How SoftWave Is Different
Extracorporeal shockwave therapy (ESWT) uses acoustic pressure waves — not electromagnetic fields — to trigger the body’s regenerative response. Within ESWT, SoftWave is distinct: rather than focusing energy on a single narrow point, SoftWave technology uses a patented parabolic reflector applicator to deliver broad-focused, low-intensity acoustic waves across a wide treatment zone (approximately 7 cm x 12 cm). These waves reach both superficial and deep tissue in a single pass.
Broad-Focused Delivery
That broad-focused delivery is why SoftWave carries FDA clearances spanning pain relief, improved circulation, tissue activation, wound healing, diabetic ulcers, burns, and connective tissue repair — a wider indication set than most focused-energy devices. For a practice, that breadth is the purchasing advantage: one SoftWave system can serve musculoskeletal, wound care, urology, sports medicine, and aesthetic patients, rather than a single clinical niche.
EMTT vs. Shockwave Therapy: Key Differences
When comparing EMTT vs. shockwave therapy as a purchase, the decision comes down to underlying technology, mechanism, breadth of clinical application, and how many of your patients each device can actually treat. Both are non-invasive, but EMTT uses high-frequency electromagnetic fields, while SoftWave uses patented electrohydraulic acoustic waves for broad-focused energy delivery.
READ: Best Shockwave Therapy Machine for Providers
The table below highlights key differences:
| Feature | EMTT | SoftWave Therapy |
| Representative Device | MAGNETOLITH (STORZ Medical) | SoftWave (Tissue Regeneration Technologies) |
| Technology | High-frequency electromagnetic fields, up to 80 mT | Acoustic waves via a patented parabolic reflector for broad-focused energy |
| Type of Wave | Electromagnetic fields | Electrohydraulic acoustic shockwaves |
| Column of Energy | Narrow, deep penetration | Broad coverage (7 cm x 12 cm), superficial and deep tissue |
| Energy | Moderate to high intensity | Low-intensity range |
| Mechanism of Action | Electroporation and piezoelectric effects stimulate osteoblastogenesis and angiogenesis | Stimulates angiogenesis, inflammation modulation, tissue repair, and regeneration |
| Target Area | Primarily musculoskeletal tissue and bone | Broad — musculoskeletal, wound healing, urology, aesthetics |
| Primary Use | Bone healing, non-union fractures, implant osseointegration, chronic MSK conditions | MSK pain (tendinopathies, osteoarthritis, ligament injuries) and wound healing incl. diabetic foot ulcers |
| FDA Clearances | Chronic musculoskeletal pain, osteonecrosis, bone healing | Pain relief, tissue activation, improved circulation, burns, diabetic ulcers, wound healing, connective tissue repair |
| Applicator Head | Hard-tip applicator | Flexible membrane |
| Patient Comfort | Minimal discomfort, no anesthesia | Highly tolerable, no anesthesia; energy adjusted to patient feedback |
| Frequency of Use | Multiple sessions over several weeks | Faster protocols, fewer sessions; response often reported after the first session |
| Combined Use | Frequently paired with ESWT in clinical protocols | Standalone or alongside other modalities |
| Best-Fit Practice | Bone- and regeneration-focused caseloads | Broad MSK, wound care, urology, sports medicine, aesthetics |
Become a SoftWave Provider Today
Enhance patient care and expand your practice with SoftWave Therapy’s innovative, evidence-based technology. Unlike EMTT, SoftWave offers broader treatment coverage and versatility addressing a range from chronic pain to wound healing, and aesthetics. Its low-intensity wide and deep energy distribution allows for greater accuracy and precision in treating the injured area. Pain patients often notice relief after just one session.
Join leading medical centers and sports organizations utilizing SoftWave’s patented, broad-focused technology to treat more conditions effectively and achieve better outcomes.
Contact us today to learn how SoftWave can transform your practice. Become a SoftWave provider today.
